Published on November 9, 2014
This study will investigate how the breast cancer treatments that KRAS-variant women undergo during their first breast cancer diagnosis impact their risk for a second, independent breast cancer. This study will help 1 in 5 women with breast cancer know which treatments mitigate their risk of second breast cancers. Study participants do not need to know their KRAS-variant status in order to participate. Take our eligibility survey at MiraKind.org.
1. Help us determine how breast cancer treatments impact second breast cancer risk for KRAS-variant women. 1 in 5 These women are Help us understand women with breast 2X as likely to develop a . cancer carryagenetic Second breast mutation called the Second, Independeﬁt cancers for these KRAs-Variant breast cancer women Learn how you can enroll in or support this study!